Market Overview

Collegium Pharmaceutical's Earnings: A Preview


On Wednesday, August 05, Collegium Pharmaceutical (NASDAQ: COLL) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

Earnings and Revenue

Sell-side analysts expect Collegium Pharmaceutical's EPS to be near $0.2 on sales of $74.40 million. In the same quarter last year, Collegium Pharmaceutical posted EPS of $-0.140 on sales of $75.04 million. The Wall Street estimate would represent a 242.86% increase in the company's earnings. Here's how the Collegium Pharmaceutical's reported EPS has stacked up against analyst estimates in the past:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019
EPS Estimate 0.37 -0.10 -0.15 -0.19
EPS Actual 0.01 -0.07 -0.18 -0.14
Revenue Estimate 77.08 M 73.33 M 74.46 M 75.82 M
Revenue Actual 76.51 M 74.20 M 72.94 M 75.04 M

Stock Performance

Over the last 52-week period, shares are up 54.34%. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release.

Don't be surprised to see the stock move on comments made during its conference call. Collegium Pharmaceutical is scheduled to hold the call at 16:30:00 ET and can be accessed here:


Related Articles (COLL)

View Comments and Join the Discussion!

Posted-In: Earnings